Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Magro

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|May 13, 2014
Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infectionN Nazareth, F Magro, J Silva, et al.
Porto Biomedical Journal|April 8, 2020
Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease - A systematic review and meta-analysis: <b>PS083</b>M M Estevinho, J Afonso, I Rosa, et al.
Inflammatory Bowel Diseases|February 27, 2010
Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1aS Rodrigues, F Magro, J Soares, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Severe gram positive bacterial infection in an ulcerative colitis patient treated with InfliximabM Marques, S Rodrigues, E Mariz, et al.
Digestive Diseases and Sciences|February 12, 2002
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel diseaseF Magro, M A Vieira-Coelho, S Fraga, et al.
Digestive Diseases and Sciences|September 28, 2005
Gingival hyperplasia as a first manifestation of Crohn's diseaseP Mergulhão, F Magro, P Pereira, et al.
Therapeutic Advances in Gastroenterology|September 29, 2018
The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levelsF Magro, C Rocha, A I Vieira, et al.
Digestive Diseases and Sciences|September 16, 2006
Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatmentF Magro, E Cunha, F Araujo, et al.
Revista De Gastroenterologia De Mexico|December 10, 2014
[Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]A Dignass, R Eliakim, F Magro, et al.
Journal of Crohn'S & Colitis|January 13, 2022
ECCO Position on Harmonisation of Crohn's Disease Mucosal HistopathologyF Magro, J Sabino, F Rosini, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|May 13, 2014
Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infectionN Nazareth, F Magro, J Silva, et al.
Porto Biomedical Journal|April 8, 2020
Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease - A systematic review and meta-analysis: <b>PS083</b>M M Estevinho, J Afonso, I Rosa, et al.
Inflammatory Bowel Diseases|February 27, 2010
Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1aS Rodrigues, F Magro, J Soares, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Severe gram positive bacterial infection in an ulcerative colitis patient treated with InfliximabM Marques, S Rodrigues, E Mariz, et al.
Digestive Diseases and Sciences|February 12, 2002
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel diseaseF Magro, M A Vieira-Coelho, S Fraga, et al.
Digestive Diseases and Sciences|September 28, 2005
Gingival hyperplasia as a first manifestation of Crohn's diseaseP Mergulhão, F Magro, P Pereira, et al.
Therapeutic Advances in Gastroenterology|September 29, 2018
The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levelsF Magro, C Rocha, A I Vieira, et al.
Digestive Diseases and Sciences|September 16, 2006
Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatmentF Magro, E Cunha, F Araujo, et al.
Revista De Gastroenterologia De Mexico|December 10, 2014
[Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)]A Dignass, R Eliakim, F Magro, et al.
Journal of Crohn'S & Colitis|January 13, 2022
ECCO Position on Harmonisation of Crohn's Disease Mucosal HistopathologyF Magro, J Sabino, F Rosini, et al.
Pageof 5